Cargando…
Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris
Viral Nervous Necrosis (VNN) causes high mortality and reduced growth in farmed European sea bass (Dicentrarchus labrax) in the Mediterranean. In the current studies, we tested a novel Pichia-produced virus-like particle (VLP) vaccine against VNN in European sea bass, caused by the betanodavirus “Re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147411/ https://www.ncbi.nlm.nih.gov/pubmed/34063318 http://dx.doi.org/10.3390/vaccines9050447 |
_version_ | 1783697624739610624 |
---|---|
author | Barsøe, Sofie Toffan, Anna Pascoli, Francesco Stratmann, Ansgar Pretto, Tobia Marsella, Andrea Er-Rafik, Mériem Vendramin, Niccolò Olesen, Niels J. Sepúlveda, Dagoberto Lorenzen, Niels |
author_facet | Barsøe, Sofie Toffan, Anna Pascoli, Francesco Stratmann, Ansgar Pretto, Tobia Marsella, Andrea Er-Rafik, Mériem Vendramin, Niccolò Olesen, Niels J. Sepúlveda, Dagoberto Lorenzen, Niels |
author_sort | Barsøe, Sofie |
collection | PubMed |
description | Viral Nervous Necrosis (VNN) causes high mortality and reduced growth in farmed European sea bass (Dicentrarchus labrax) in the Mediterranean. In the current studies, we tested a novel Pichia-produced virus-like particle (VLP) vaccine against VNN in European sea bass, caused by the betanodavirus “Red-Spotted Grouper Nervous Necrosis Virus” (RGNNV). European sea bass were immunized with a VLP-based vaccine formulated with different concentrations of antigen and with or without adjuvant. Antibody response was evaluated by ELISA and serum neutralization. The efficacy of these VLP-vaccine formulations was evaluated by an intramuscular challenge with RGNNV at different time points (1, 2 and 10 months post-vaccination) and both dead and surviving fish were sampled to evaluate the level of viable virus in the brain. The VLP-based vaccines induced an effective protective immunity against experimental infection at 2 months post-vaccination, and even to some degree at 10 months post-vaccination. Furthermore, the vaccine formulations triggered a dose-dependent response in neutralizing antibodies. Serologic response and clinical efficacy, measured as relative percent survival (RPS), seem to be correlated with the administered dose, although for the individual fish, a high titer of neutralizing antibodies prior to challenge was not always enough to protect against disease. The efficacy of the VLP vaccine could not be improved by formulation with a water-in-oil (W/O) adjuvant. The developed RGNNV-VLPs show a promising effect as a vaccine candidate, even without adjuvant, to protect sea bass against disease caused by RGNNV. However, detection of virus in vaccinated survivors means that it cannot be ruled out that survivors can transmit the virus. |
format | Online Article Text |
id | pubmed-8147411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81474112021-05-26 Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris Barsøe, Sofie Toffan, Anna Pascoli, Francesco Stratmann, Ansgar Pretto, Tobia Marsella, Andrea Er-Rafik, Mériem Vendramin, Niccolò Olesen, Niels J. Sepúlveda, Dagoberto Lorenzen, Niels Vaccines (Basel) Article Viral Nervous Necrosis (VNN) causes high mortality and reduced growth in farmed European sea bass (Dicentrarchus labrax) in the Mediterranean. In the current studies, we tested a novel Pichia-produced virus-like particle (VLP) vaccine against VNN in European sea bass, caused by the betanodavirus “Red-Spotted Grouper Nervous Necrosis Virus” (RGNNV). European sea bass were immunized with a VLP-based vaccine formulated with different concentrations of antigen and with or without adjuvant. Antibody response was evaluated by ELISA and serum neutralization. The efficacy of these VLP-vaccine formulations was evaluated by an intramuscular challenge with RGNNV at different time points (1, 2 and 10 months post-vaccination) and both dead and surviving fish were sampled to evaluate the level of viable virus in the brain. The VLP-based vaccines induced an effective protective immunity against experimental infection at 2 months post-vaccination, and even to some degree at 10 months post-vaccination. Furthermore, the vaccine formulations triggered a dose-dependent response in neutralizing antibodies. Serologic response and clinical efficacy, measured as relative percent survival (RPS), seem to be correlated with the administered dose, although for the individual fish, a high titer of neutralizing antibodies prior to challenge was not always enough to protect against disease. The efficacy of the VLP vaccine could not be improved by formulation with a water-in-oil (W/O) adjuvant. The developed RGNNV-VLPs show a promising effect as a vaccine candidate, even without adjuvant, to protect sea bass against disease caused by RGNNV. However, detection of virus in vaccinated survivors means that it cannot be ruled out that survivors can transmit the virus. MDPI 2021-05-02 /pmc/articles/PMC8147411/ /pubmed/34063318 http://dx.doi.org/10.3390/vaccines9050447 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Barsøe, Sofie Toffan, Anna Pascoli, Francesco Stratmann, Ansgar Pretto, Tobia Marsella, Andrea Er-Rafik, Mériem Vendramin, Niccolò Olesen, Niels J. Sepúlveda, Dagoberto Lorenzen, Niels Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris |
title | Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris |
title_full | Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris |
title_fullStr | Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris |
title_full_unstemmed | Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris |
title_short | Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris |
title_sort | long-term protection and serologic response of european sea bass vaccinated with a betanodavirus virus-like particle produced in pichia pastoris |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147411/ https://www.ncbi.nlm.nih.gov/pubmed/34063318 http://dx.doi.org/10.3390/vaccines9050447 |
work_keys_str_mv | AT barsøesofie longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT toffananna longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT pascolifrancesco longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT stratmannansgar longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT prettotobia longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT marsellaandrea longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT errafikmeriem longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT vendraminniccolo longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT olesennielsj longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT sepulvedadagoberto longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris AT lorenzenniels longtermprotectionandserologicresponseofeuropeanseabassvaccinatedwithabetanodavirusviruslikeparticleproducedinpichiapastoris |